(Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection in the outer ear canal, met the main goal in a late-stage trial. AOE, also known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback